Trial intelligence / Profile preview

Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI

NCT06850831Phase 2Completed

Start
Apr 2025
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in ST elevation myocardial infarction (STEMI). Started Apr 2025; status: completed.

02

Drugs

acetylcysteine
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT06850831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06850831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call